PTHLH and neoplasm: Upon proliferation in bone, tumor cells perturb the tightly balanced bone remodeling cycle through secretion of factors such as parathyroid hormone-related protein (PTHrP) and interleukins (ILs) that stimulate osteoblasts to produce increased levels of receptor activator of NF-κB ligand (RANKL).